Medichem Presents Its Sustainability Report 2024 (Non-financial information)
05/08/2025
Medichem reaffirms its commitment to transparency and sustainability with the publication of its fourth Non-Financial Information Statement (EINF), covering fiscal year 2024.
The report complies with Law 11/2018, aligns with GRI and European Commission standards, and anticipates future requirements under the Corporate Sustainability Reporting Directive (CSRD).
Key Achievements in 2024
- SCOPE 3 Emissions & ESG Commitments: Progress in measuring and reducing indirect emissions, aligned with Science Based Targets initiative (SBTi) and Carbon Disclosure Project (CDP) frameworks.
- Double Materiality Analysis: Our sustainability efforts have been evaluated from both financial and non-financial perspectives, analyzing every point of our value chain. This enables us to adopt a more holistic approach, focusing on a more tangible and immediate sustainability.
- EU Taxonomy eligibility: A comprehensive study demonstrated our alignment with the European Union taxonomy, highlighting our commitment to sustainable economic activities and investment transparency.
These milestones are clear evidence that Medichem is focused on responsible management, positioning us as a visionary organization capable of generating long-term value in a market that evolves, adapts, and demands the highest level of care at every stage.
Looking Ahead
We continue with our clear goals, as we do every year: Innovation and Adaptation.
Medichem remains steadfast in its mission to create a positive impact on society and the environment.
